The International Myeloma Foundation (IMF) will host the 10th Annual International Myeloma Working Group (IMWG) Summit from June 10–12 in Amsterdam. More than 100 of the world’s top myeloma experts will attend the 2019 Summit, which convenes on the eve of the 24th Annual Congress of the European Hematology Association (EHA), also in Amsterdam. Throughout the IMWG Summit, myeloma experts will debate how best to treat patients in 2019 and beyond.
Dr. Casey Greene, University of Pennsylvania, will deliver a keynote talk on the role artificial intelligence can play in cancer research.
“The Summit provides the opportunity for us to evaluate the latest developments in myeloma research and treatment and come to a consensus on how best to incorporate these advances into recommendations for improving treatment for myeloma patients globally,” said IMF Chairman Dr. Brian G.M. Durie.
Researchers in Amsterdam will grapple with the use of CAR T-cell therapy and other immune therapy approaches; when to treat smoldering myeloma; the current status of MRD; and improving patient access to new drugs. In addition, investigators from the IMF’s Black Swan Research Initiative® (BSRI) team will convene in the IMF’s signature effort to cure myeloma.
Patients, caregivers and doctors around the world can view a live-stream broadcast from the Summit on Wednesday, June 12. The IMF’s popular IMWG Conference Series, "Making Sense of Treatment,"[link TK] will feature a panel of international myeloma experts—Drs. Brian Durie, Philippe Moreau, and Joseph Mikhael—who will distill, debate, and discuss news from the Summit, the European Hematological Association (EHA) meeting, and the 2018 Annual Meeting of the American Society of Clinical Oncology (ASCO) during a 60-minute webcast. The live event starts at 6 am ET. The live and archived webcast can be found at myeloma.org.
Additional IMWG Summit highlights include:
- The presentation of the IMF’s 17th Annual IMWG Awards. Meletios Dimopoulos, MD will receive the Robert A. Kyle Lifetime Achievement Award. The award honors an individual whose body of work has made significant contributions to myeloma research and patient care. María-Victoria Mateos, MD will receive the Brian G.M. Durie Outstanding Achievement Award, which recognizes excellence in myeloma research.;
- A meeting of the IMF Global Myeloma Action Network (GMAN) will bring together more than 30 myeloma patient groups from around the world to raise global awareness of myeloma, improve patient outcomes, and ensure access to life-saving treatments.
“The IMF is proud to lead this unprecedented collaborative event that brings together the world’s experts in myeloma to advance treatment and research that will lead to a cure,” said IMF President Susie Durie.